The GPRIN3 Monoclonal Antibody (PAC013470) is a cutting-edge research tool designed for the investigation of GPRIN3, a G-protein regulated inducer of neurite outgrowth. This antibody, produced using high-quality materials, is highly specific to human samples and has been validated for use in a variety of applications, including Western blot and immunofluorescence.GPRIN3 is a key player in neuronal development and function, with implications in various neurological disorders and diseases. By targeting GPRIN3, researchers can gain insights into its role in neurite outgrowth and synaptic plasticity, offering potential avenues for therapeutic intervention in conditions such as Alzheimer's disease, Parkinson's disease, and schizophrenia.
This antibody offers researchers a reliable tool for studying GPRIN3 in various cell types and tissues, making it an essential component of studies in neuroscience and neurology. With its high specificity and sensitivity, the GPRIN3 Monoclonal Antibody is a valuable asset for advancing our understanding of neurodevelopmental processes and neurological disorders.
